跳至主要内容
临床试验/NL-OMON39699
NL-OMON39699已完成3 期

The effect of glycopyrroniumbromide on nocturnal clozapine induced sialorrhea in psychiatric patients: a randomized, cross-over, double blind, placebo controlled trial with an extended open label phase (QUITSPIT study) - QUITSPIT-study

niversitair Medisch Centrum Utrecht0 个研究点目标入组 33 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
33

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -patients using clozapine who are diagnosed with schizophrenia, a schizoaffective disorder or other psychiatric condition meeting DSM-IV criteria;
  • -a clozapine dosage that remained unchanged for one months prior to inclusion;
  • -age between 18 and 65 years;
  • -nocturnal sialorrhea defined as a score > 2 on the PGI-S (Patient Global Impression of Severity Questionnaire)
  • -no change in dosages of specific comedication (clonidine, sulpride, moclobemide) that potentially reduces salivary flow for 16 days prior to inclusion
  • -the patients is able to answer questionnaires during a weekly consultation (by telephone) with the researcher
  • - the patient is willing to give informed consent for participating in the study
  • -the patient is, according to the treating psychiatrist, competent and able to give informed consent for participating in the study.

排除标准

  • -known hypersensitivity to glycopyroniumbromide, sorbic acid or saccharine sodium;
  • -a comorbidity associated with sialorrhea (Parkinsons disease, cerebral palsy);
  • -one of the following comorbidities: inadequately treated constipation, urine retention, bladder obstruction
  • -concurrent use of anticholinergic agents: tricyclic antidepressants or anticholinergics (atropine, ipratropiumbromide, trihexyfenidyl,
  • biperiden, scopolamine, oxybutinine);
  • -concurrent use of medications that potentially interact with glycopyrroniumbromide
  • (potassium chloride retard tablets, digoxine, corticosteroids)
  • -pregnancy or lactation
  • -a history of myasthenia gravis, cardiac arrhythmia, symptomatic coronary insufficiency, glaucoma, pyloris stenosis, paralytic ileus, prostate hypertrophy, renal failure
  • -unable to autonomic medication intake

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验

The effect of glycopyrroniumbromide on nocturnal... | 临床试验